Watch the NEJM Quick Take video of this trial comparing one dose of an HPV vaccine with two doses in girls 12 to 16 years of age.
HPV vaccination could prevent most cervical cancers, but only 27% of eligible adolescent girls worldwide have received the vaccine. Data suggest that a single dose may be protective. New research findings are summarized in a short video.